Yanfen Feng
-
- Viral-associated cancers and disorders 11
-
- Lymphoma Diagnosis and Treatment 12
- Genetic factors in colorectal cancer 3
-
- Cancer-related molecular mechanisms research 5
-
- Myasthenia Gravis and Thymoma 3
-
- Esophageal Cancer Research and Treatment 5
-
- Lung Cancer Treatments and Mutations 5
-
- RNA modifications and cancer 4
- Co-authors
- Fang WangYiyan LeiYuhua HuangHui‐Lan RaoHonghe LuoHaiyun WangQiong ShaoYu Zhang
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yanfen Feng
37 papers receiving 421 citations
Peers
Comparison fields: 5 of 62
- Oncology 201
- Pathology and Forensic Medicine 109
- Cancer Research 85
- Otorhinolaryngology 22
- Neurology 62
Countries citing papers authored by Yanfen Feng
This map shows the geographic impact of Yanfen Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfen Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfen Feng more than expected).
Fields of papers citing papers by Yanfen Feng
This network shows the impact of papers produced by Yanfen Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfen Feng. The network helps show where Yanfen Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanfen Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 17 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 18 | |
| 10 | 2020 | 13 | |
| 11 | 2020 | 8 | |
| 12 | 2019 | 16 | |
| 13 | 2019 | 4 | |
| 14 | 2019 | 40 | |
| 15 | 2018 | 13 | |
| 16 | 2018 | 11 | |
| 17 | 2017 | 28 | |
| 18 | 2017 | 12 | |
| 19 | 2017 | 31 | |
| 20 | [Analysis of mature T-cell and NK-cell lymphoma with CD30 expression based on latest WHO classification]. | 2014 | 2 |
About Yanfen Feng
Yanfen Feng is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 39 papers that have together received 429 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (11 papers), Esophageal Cancer Research and Treatment (5 papers), Cancer-related molecular mechanisms research (5 papers), Lung Cancer Treatments and Mutations (5 papers), RNA modifications and cancer (4 papers), Myasthenia Gravis and Thymoma (3 papers) and Genetic factors in colorectal cancer (3 papers). The work is most often cited by research in Oncology (201 citations), Pathology and Forensic Medicine (109 citations) and Cancer Research (85 citations). Yanfen Feng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Fang Wang, Yiyan Lei, Yuhua Huang, Hui‐Lan Rao, Honghe Luo, Haiyun Wang, Qiong Shao, Yu Zhang, Xiaoyan Wu and Xin An.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.